Composition

Each prolonged release capsule contains 8,16,24mg galantamine (as hydrobromide ) 

 excipients: as pellets 

Indications

Galantamine is indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer.

Composition

Each capsule (pellets) contains:

40 mg or 80 mg or 125 mg aprepitant.

Indications

1. Prevention of Chemotherapy Induced Nausea and Vomiting (CINV): the capsules, in combination with other antiemetic agents, are indicated in patients 12 years of age and older for the prevention of: 

• Acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. 

• Nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).

2. Prevention of Postoperative Nausea and Vomiting (PONV) in adults

Composition

Each delayed release capsule contains enteric coated pellets of:

22.4mg duloxetine hydrochloride eq: 20 mg duloxetine.

33.7 mg duloxetine hydrochloride eq: 30 mg duloxetine.

67.3 mg duloxetine hydrochloride eq: 60 mg duloxetine. 

Indications

- DULOXETINE is indicated for the treatment of major depressive disorder (MDD).

- DULOXETINE is indicated for the acute treatment of generalized anxiety disorder (GAD).

- DULOXETINE is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPNP).

- DULOXETINE is indicated for the management of fibromyalgia (FM).

- DULOXETINE is indicated for the management of the Chronic Musculoskeletal Pain.

Composition

Each capsule contains: 10mg or 20mg Fluoxetine 

Excipients: anhydrous colloidal silica, Maize starch, Talc, magnesium stearate. 

Indications

Adults:

1- Major depressive episodes.

2- Obsessive-compulsive disorder.

3-Bulimia nervosa: Fluoxetine is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity. 

Children and Adolescents Aged 8 Years and Above:

Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions, antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy.

Composition

One capsule (pellets) contains: 125mg Aprepitant. 

Two capsules (pellets) contains: 80 mg Aprepitant.

Indications

1. Prevention of Chemotherapy Induced Nausea and Vomiting (CINV): the capsules, in combination with other antiemetic agents, are indicated in patients 12 years of age and older for the prevention of: 

• Acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. 

• Nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).

2. Prevention of Postoperative Nausea and Vomiting (PONV) in adults